SCHEMBL2001308

SCHEMBL2001308

CCN(C)C(c1ccc(-c2ccc(F)cc2)cc1)c1cn[nH]c1C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP17A1 P05093 2/20 0.36
ROCK2 O75116 1/20 0.33
METAP2 P50579 1/20 0.33
EGFR P00533 1/20 0.33
HTR2A P28223 1/20 0.33
HTR2C P28335 1/20 0.33
TGFBR1 P36897 2/20 0.33
KDM4E B2RXH2 1/20 0.33
MEN1 O00255 1/20 0.33
TSHR P16473 1/20 0.33
KMT2A Q03164 1/20 0.33
KCNH2 Q12809 1/20 0.32
GRIN2B Q13224 1/20 0.32
AOC3 Q16853 1/20 0.32
AKT2 P31751 1/20 0.32
SLC6A2 P23975 1/20 0.32
SLC6A4 P31645 1/20 0.32
SLC6A3 Q01959 1/20 0.32
HRH3 Q9Y5N1 1/20 0.32
CYP3A4 P08684 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1998316 0.72 HRH3 (0.45) HTR2AHTR2CKDM4EMEN1KMT2A
SCHEMBL1998048 0.69 MAPT (0.36) TGFBR1KDM4EMEN1TSHRKMT2A
SCHEMBL1997982 0.68 ACHE (0.43) HTR2AHTR2CTSHRKCNH2SLC6A2
SCHEMBL5225128 0.67 NSD3 (0.45) MEN1KMT2ACYP3A4ALDH1A1
SCHEMBL12651076 0.65 AKT2 (0.66) TGFBR1KMT2AAKT2MAPK13MAPK12
SCHEMBL2001557 0.65 KCNH2 (0.37) MEN1KMT2AKCNH2GRIN2BHRH3
SCHEMBL20622896 0.62 MEN1 (0.47) CYP17A1MEN1TSHRKMT2AAOC3
SCHEMBL20148798 0.61 MAPK14 (0.50) EGFRTGFBR1KMT2AMAPK13MAPK12
SCHEMBL22931846 0.61 AKT2 (0.35) MEN1KMT2AAKT2ALDH1A1
SCHEMBL22932417 0.60 TSHR (0.36) TSHRKMT2AAKT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7960413-B2 Pyrazole compounds MERCK PATENT GMBH (DE) 2011-06-14 US disclosed
US-20060276650-A1 Pyrazole compounds MERCK PATENT GMBH (DE) 2006-12-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060276650-A1 Pyrazole compounds HTR1D, HTR1A, HTR3A CYP17A1 1714/4885ROCK2 3222/4885METAP2 3068/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.